Acceleron Pharma Inc Revenu Y/Y
Quel est le Revenu Y/Y de Acceleron Pharma Inc?
Le Revenu Y/Y de Acceleron Pharma Inc est 6.39%
Quelle est la définition de Revenu Y/Y?
La croissance annuelle des revenus des trois dernières années correspond à la croissance moyenne des revenus d’une année sur l’autre au cours des trois dernières années.
The yearly revenue growth rate is calculated as the percentage change in revenue over the trailing twelve months. For this specific metric, the calculation takes into account a series of the last eight quarterly revenues. The revenue growth is useful for determining the success of the company expanding its main business. Revenue growth of 5% to 10% is usually considered good for large-cap companies. For other companies, a sales growth of over 10% is more desirable.
Revenu Y/Y des entreprises dans Health Care secteur sur NASDAQ par rapport à Acceleron Pharma Inc
Que fait Acceleron Pharma Inc?
Acceleron is a biopharmaceutical company dedicated to the discovery, development, and commercialization of therapeutics to treat serious and rare diseases. Acceleron's leadership in the understanding of TGF-beta superfamily biology and protein engineering generates innovative compounds that engage the body's ability to regulate cellular growth and repair.
Entreprises avec revenu y/y similaire à Acceleron Pharma Inc
- Nanogate SE a Revenu Y/Y de 6.37%
- Magna International a Revenu Y/Y de 6.37%
- loanDepot a Revenu Y/Y de 6.38%
- Tesco Plc a Revenu Y/Y de 6.38%
- Dominion Resources a Revenu Y/Y de 6.38%
- Theradiag SA a Revenu Y/Y de 6.38%
- Acceleron Pharma Inc a Revenu Y/Y de 6.39%
- Luceco plc a Revenu Y/Y de 6.39%
- Magna Gold a Revenu Y/Y de 6.39%
- Advanced Micro Devices a Revenu Y/Y de 6.40%
- Universal a Revenu Y/Y de 6.40%
- Hitech a Revenu Y/Y de 6.40%
- AstraZeneca Pharma India a Revenu Y/Y de 6.41%